Open Access Government produces compelling and informative news, publications, eBooks, and academic research articles for the public and private sector looking at health, diseases & conditions, workplace, research & innovation, digital transformation, government policy, environment, agriculture, energy, transport and more.
Home Search
chemotherapy - search results
If you're not happy with the results, please do another search
TheraVision: An oncolytic virus platform technology for a personalised virus-immunotherapy
Prof Dr Susanne M Bailer, Fraunhofer Institute for Interfacial Engineering and Biotechnology IGB, explains the possibilities of an oncolytic virus platform technology.
Medical cannabis & the future of cancer treatments
Dr Stephen Barnhill MD, CEO of Apollon Formularies Plc, examines medical cannabis and the future of cancer treatments across the UK and the European healthcare sectors.
Amyloidosis: A rare but devastating blood condition
Dr Peter Diamond, Head of Research from the Leukaemia Foundation, describes what we need to know about amyloidosis, a rare but devastating blood condition
Third known case of HIV remission after stem cell transplant
After receiving a cord blood stem cell transplant to treat acute myeloid leukaemia a woman with diagnosed HIV has had no detectable levels of HIV for 14 months
New potential therapy for aggressive bladder cancer
Led by Yale Cancer Center, new research shows that enfortumab vedotin is an effective alternative for patients with muscle-invasive bladder cancer (MIBC)
Drug for ovarian cancer shows 52% reduction in death
Scientists have began using trametinib – used to treat skin and lung cancers – for ovarian cancer, showing that it can significantly slow the progression of the cancer.
Prospects for minimally invasive and optimally effective cancer immunotherapy
Here, Professor of Biochemistry, Microbiology & Immunology at the University of Saskatchewan, Peter Betscher, explains how he is dedicated towards realising Robert North’s vision.
Drug gives 34% protection against lung cancer recurrence
The NHS have gained a new drug, atezolizumab, which can give 34% protection against lung cancer recurrence or death, post-chemotherapy.
Getting personal in brain tumour therapy: Matching therapies to patients
Sean E. Lawler PhD from Brown University Cancer Center, an experienced scientist in the brain tumour field
Artificial Intelligence solutions for healthcare delivery
Chaith Kondragunta, CEO at AIRA Matrix Private Limited, details Artificial Intelligence-based solutions that can positively impact prostate cancer outcomes.
miRNAs in brain cancer therapy – Mighty things from small beginnings grow
Dr Hernando Lopez-Bertoni at the Department of Neurology, Johns Hopkins School of medicine, discusses the development of miRNAs in brain cancer therapy
COVID vaccine: Parental hesitancy for kids with cancer
A survey shows parents of kids with cancer have similar hesitancy rates as the wider population to vaccinate their children against COVID-19.
Early detection of pancreatic cancer – The EUROPAC Research Trial
Dr Deborah Lee, Dr Fox Online Pharmacy, tells us all about the European pancreatic cancer early detection trial (EUROPAC).
Death rate from Parkinson’s disease rises in US
The death rate from Parkinson’s disease has risen by 63% in the United States, according to a new study.
New cancer treatment creates best “overall survival ever”
A new cancer treatment, an immunotherapy combination as opposed to gruelling chemotherapy, is saving the lives of head and neck cancer patients.
Black women face racial disparities in breast cancer screening
Black women face higher mortality rates and recurrence of breast cancer, according to researchers from University of Illinois Chicago.
Optimising infection control post-pandemic
Luke S. P. Moore, Infectious Diseases Physician and Clinical Microbiologist on behalf of the Healthcare Infection Society, directs our thoughts to optimising our control of infections and looks forward to the post-pandemic period.
A look at brain tumour diagnosis & therapy
Andrew Brodbelt, Consultant Neurosurgeon at The Walton Centre NHS Foundation Trust, describes what we need to know about brain tumour diagnosis & therapy.
The future of vascular imaging technology
Researchers from Kyoto University Hospital and Preemptive Medicine and Lifestyle Related Disease Research Center, describe the future of vascular imaging technology, including how photoacoustic imaging targets tumour vessels in breast cancer.
DPYD genotyping to improve patients’ therapy response
Here Yourgene Health, a molecular diagnostics company with products and technologies that enable precision medicine in oncology from bench to clinic, discuss genetic testing - or more specifically, pharmacogenomics.
